AU7293896A - Pharmaceutical composition containing a blood-brain barrier transport enhancer - Google Patents

Pharmaceutical composition containing a blood-brain barrier transport enhancer

Info

Publication number
AU7293896A
AU7293896A AU72938/96A AU7293896A AU7293896A AU 7293896 A AU7293896 A AU 7293896A AU 72938/96 A AU72938/96 A AU 72938/96A AU 7293896 A AU7293896 A AU 7293896A AU 7293896 A AU7293896 A AU 7293896A
Authority
AU
Australia
Prior art keywords
blood
pharmaceutical composition
composition containing
brain barrier
barrier transport
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72938/96A
Inventor
Esteban Pombo Villar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU7293896A publication Critical patent/AU7293896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
AU72938/96A 1995-10-17 1996-10-16 Pharmaceutical composition containing a blood-brain barrier transport enhancer Abandoned AU7293896A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9521322.9A GB9521322D0 (en) 1995-10-17 1995-10-17 Organic compounds
GB9521322 1995-10-17
PCT/EP1996/004494 WO1997014439A1 (en) 1995-10-17 1996-10-16 Pharmaceutical composition containing a blood-brain barrier transport enhancer

Publications (1)

Publication Number Publication Date
AU7293896A true AU7293896A (en) 1997-05-07

Family

ID=10782492

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72938/96A Abandoned AU7293896A (en) 1995-10-17 1996-10-16 Pharmaceutical composition containing a blood-brain barrier transport enhancer

Country Status (4)

Country Link
AU (1) AU7293896A (en)
GB (1) GB9521322D0 (en)
WO (1) WO1997014439A1 (en)
ZA (1) ZA968764B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
DOP2000000107A (en) 1999-12-01 2002-09-16 Agouron Pharmaceutical Inc COMPOUNDS, COMPOSITIONS AND METHODS TO STIMULATE THE GROWTH AND LENGTH OF NEURONS
FR2806626B1 (en) * 2000-03-22 2003-11-28 Centre Nat Rech Scient USE OF MODULATING SUBSTANCES FOR THE EXPRESSION OR FUNCTION OF A PROTEIN INVOLVED IN THE CELL CYCLE FOR THE TREATMENT OR PREVENTION OF ACUTE NEURAL INJURIES
GB0117645D0 (en) * 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
GB0125443D0 (en) 2001-10-23 2001-12-12 Novartis Ag Organic Compounds
AU2007237187B2 (en) * 2002-07-16 2010-08-05 Biotica Technology Limited Production of polyketides

Also Published As

Publication number Publication date
WO1997014439A1 (en) 1997-04-24
GB9521322D0 (en) 1995-12-20
ZA968764B (en) 1998-04-17

Similar Documents

Publication Publication Date Title
AUPN605795A0 (en) Analgesic pharmaceutical composition
AU5177993A (en) Pharmaceutical compositions containing a calcitonin
AU5402296A (en) Pharmaceutical composition for transdermic administration
AU6216296A (en) Pharmaceutical compositions
ZA965368B (en) A pharmaceutical formulation
HUP9802086A3 (en) Pharmaceutical composition for piperidinoalkanol compounds
ZA96124B (en) A pharmaceutical formulation
AU6917296A (en) Improved vial floss dispenser
AU6904896A (en) Pharmaceutical compounds
AU5155096A (en) Pharmaceutical composition
AU7904998A (en) Pharmaceutical composition containing peptichemio
IL112639A0 (en) A pharmaceutical composition containing pravastin
AU3542993A (en) Pharmaceutical compounds
AU5274096A (en) Pharmaceutical compositions
AU7293896A (en) Pharmaceutical composition containing a blood-brain barrier transport enhancer
AU5630596A (en) Tamper evident pharmaceutical dosage form
IL116912A0 (en) Novel pharmaceutical combination for topical administration
AU6422298A (en) Pharmaceutical composition containing a phosphorylamide and an ayntibiotic
AU3949093A (en) A pharmaceutical formulation
AU9553898A (en) Pharmaceutical compositions containing an opiate analgesic and a synergizing substance
AU4701593A (en) Oral pharmaceutical compositions comprising reduced glutathion
AU1500992A (en) Pharmaceutical compound
AU7546096A (en) Pharmaceutical compounds
ZA965367B (en) A pharmaceutical formulation
AU4959497A (en) Pharmaceutical composition containing bismuth-polyacrylic acid compounds